Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2018-10-29 Interim / Quarterly Rep…
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Quarterly Activities Report & Appendix 4C - 30 Sept. 2018 9 pages 513.2KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2018'. It contains detailed operational highlights, product development updates, joint venture information, equity placement details, and a financial snapshot including cash flow statements. The presence of Appendix 4C, which is a quarterly report format required by the ASX, and the detailed financial data for the quarter indicate this is a comprehensive interim financial report. The document is about a quarter period, contains substantive financial data and analysis, and is not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2018-10-29 English
Appendix 3B 11 pages 502.2KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new shares, including the number of securities issued, issue price, terms, and compliance with ASX rules. It includes sections on placement capacity calculations under ASX rules 7.1 and 7.1A, details of securities issued, and warranties given to ASX. The document is a formal announcement related to a new share issue and capital raising activity. It is not a full financial report, earnings release, or management discussion. It is not a proxy or voting result announcement. The content aligns with a capital or financing update regarding new share issuance and placement capacity. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the announcement itself, not just a brief notice or report publication announcement. Confidence is high due to the clear focus on new share issuance and compliance with capital raising rules.
2018-10-24 English
Investor Presentation October 2018 19 pages 1.4MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation discussing the company's products, market opportunities, collaborations, strategic initiatives, and financial positioning. It includes forward-looking statements, product descriptions, market data, partnership information, and funding plans. The content is structured as a presentation with slides and images (not included), focusing on investor information and company strategy rather than formal financial statements or regulatory disclosures. There is no indication of it being an annual or quarterly report, audit report, earnings release, or regulatory filing. The presence of forward-looking statements and detailed business and financial strategy aligns with an Investor Presentation. The document length and content support this classification rather than a brief announcement or a formal report.
2018-10-22 English
Lapse of Employee Share Options 2 pages 698.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 15 October 2018 regarding the lapse of employee share options. It provides details about the number of options lapsed and outstanding options but does not contain financial statements, management discussion, or detailed financial data. The document is relatively short (3815 characters) and serves as a notification about share option status rather than a financial report or detailed filing. It is not an annual or interim report, earnings release, or management report. It is also not a regulatory certification or voting result. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about employee share options lapsing, which does not fit into more specific categories like share issue or director dealings.
2018-10-14 English
GTG Invited to Establish Market Presence in Hainan, China 2 pages 790.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 17 September 2018 regarding Genetic Technologies Limited's invitation to establish a market presence in Hainan, China. It discusses business development, partnerships, and market entry plans but contains no financial statements, earnings data, or regulatory filings. It is a corporate announcement about strategic business expansion rather than a financial report, management change, or regulatory filing. The document length is about 5,131 characters, which is relatively short and consistent with a market announcement. There is no indication of voting results, director dealings, or capital changes. Therefore, the best fitting category is a general Regulatory Filing (RNS) as it is a regulatory announcement that does not fit into more specific categories like earnings release or management information.
2018-09-16 English
Appendix 4E and Financial Report 2018 73 pages 1.6MB
Annual Report Classification · 95% confidence The document is titled 'ASX Appendix 4E Preliminary Final Report for the year ended 30 June 2018' and includes detailed financial information for the full fiscal year ended 30 June 2018. It contains consolidated statements of comprehensive income, balance sheet, cash flows, and changes in equity, as well as notes and auditor's report. The document references the auditor PricewaterhouseCoopers and mentions the report is audited. The length is substantial (15,000 characters), indicating it is the full report, not just an announcement. Appendix 4E is a standard Australian Securities Exchange (ASX) preliminary final report, which is effectively an annual report or full year financial report. Given the comprehensive financial data and the annual period covered, this document fits the definition of an Annual Report (10-K equivalent). FY 2018
2018-08-29 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.